Results 181 to 190 of about 145,073 (355)

More than Meets the Eye: A Qualitative Investigation of the Complex Weight History Constructions of Brazilian Women Who Underwent Bariatric Surgery

open access: diamond, 2023
Mariana Dimitrov Ulian   +9 more
openalex   +2 more sources

Testing the feasibility of an intermittent low‐energy diet in women with gestational diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims The study aimed to assess feasibility, acceptability and safety of an ILED in a randomised controlled trial of ILED vs. best NHS care healthy diet and exercise advice in women with Gestational Diabetes Mellitus (GDM) with body mass index ≥27.5 kg/m2 (≥25 kg/m2 in high‐risk minority ethnic groups) in the last trimester of pregnancy ...
Elizabeth Dapre   +11 more
wiley   +1 more source

Investigating discrepancies in demand and access for bariatric surgery across different demographics in the COVID-19 era

open access: diamond, 2022
Aashna Mehta   +9 more
openalex   +1 more source

Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (SMILE)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the real‐world associations between semaglutide 2.4 mg and cardiometabolic comorbidities, biomarkers and cardiovascular risk among adults with overweight or obesity. Methods This retrospective cohort study used US claims data and laboratory measurements from the Komodo Research Database (2016–2024). Adults with obesity or with
Aleksandrina Ruseva   +11 more
wiley   +1 more source

Is Bariatric Surgery at Risk Due to Semaglutide? [PDF]

open access: yesJ Metab Bariatr Surg
Tian J   +8 more
europepmc   +1 more source

The effect of bariatric surgery on infertility in obese females

open access: diamond, 2023
Mostafa Mohammed Darwesh   +3 more
openalex   +1 more source

Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim We compared the impact of metabolic bariatric surgery (MBS) versus semaglutide on clinical outcomes in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and type 2 diabetes (T2D). Methods Patients with MASLD and T2D who had MBS or semaglutide in 2018–2023 were identified (TriNetX database).
Weronika Stupalkowska   +5 more
wiley   +1 more source

Treatment of postoperative pain in bariatric surgery

open access: diamond, 2017
Breno José Santiago Bezerra de Lima
openalex   +1 more source

Could the mechanisms of bariatric surgery hold the key for novel therapies?: report from a Pennington Scientific Symposium [PDF]

open access: bronze, 2011
Charmaine S. Tam   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy